A-770041

Biorbyt

A-770041

10

Research Use Only

99.86%

A-770041 is an orally active and selective Lck inhibitor that inhibits concanavalin A-stimulated IL-2 production in whole blood and prevents cardiac allograft rejection. A-770041 reduces pulmonary fibrosis by inhibiting TGF-beta production in regulatory T cells.

-20°C

12352200